Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 0% |
 |
Gilead SciencesGILD |
60 0% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Dec 2024 | 22 | |
| Nov 2024 | 22 | |
| Oct 2024 | 20 | |
| Sep 2024 | 23 | |
| Aug 2024 | 20 |
How do employees feel about the future at Adaptive Biotechnologies?
According to employees, the Business Outlook at Adaptive Biotechnologies is highly negative. This is reflected in the average rating of 22 out of 100, which is considered very low.
Analyzing Business Outlook, how is Adaptive Biotechnologies performing compared to its industry peers?
Adaptive Biotechnologies underperforms its industry peers when it comes to Business Outlook, ranking in the 22nd percentile.
How has the business outlook at Adaptive Biotechnologies changed over the last couple of months
In recent months, Adaptive Biotechnologies' employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at Adaptive Biotechnologies?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Adaptive Biotechnologies.
